Market Movers: High-Trend International Group (NASDAQ: HTCO) and Others Surge on Strategic News

Font: Financial Modeling Prep  • Apr 27, 2026

• High-Trend International Group (HTCO) stock surged over 239% following its strategic expansion into lithium resources transportation.
• Edgewise Therapeutics, Inc. (EDSA) and ManpowerGroup Inc. (MANE) experienced significant gains after announcing positive Phase 3 and Phase 2/3 clinical trial results, respectively.
• SigmaTron International, Inc. (SGMT) and Carmell Therapeutics Corporation (CRML) also climbed on strategic updates and acquisition news, underscoring investor focus on fundamental business growth.

Several companies saw major stock price increases driven by significant business developments. The market gains are led by High-Trend International Group (NASDAQ: HTCO), which specializes in ocean transportation and marine decarbonization. Other notable performers include companies in the biopharmaceutical sector and materials sectors, each announcing positive news that captured investor attention.

High-Trend International Group stock surged 239.73%, a $26.97 increase, to close at $38.22. The company announced a strategic expansion into the lithium resources transportation business. This move aims to improve its mix of transported goods and increase profit stability for its shareholders.

In the biopharmaceutical space, Edgewise Therapeutics, Inc. (NASDAQ: EDSA) shares rose 53.86%, or $3.91, to $11.17. The company reported positive Phase 3 results for its drug Paridiprubart, which significantly reduced mortality in patients with acute respiratory distress syndrome (ARDS). This success led to an invitation for an oral showcase at the Respiratory Innovation Summit.

Similarly, ManpowerGroup Inc. (NYSE: MANE) saw its stock jump 47.55%, or $32.26, to $100.10. The firm reported positive results from a Phase 2/3 trial for its hair loss treatment, VDPHL01. These trials are crucial late-stage studies that test a drug's effectiveness and safety on a large group of patients before seeking market approval.

SigmaTron International, Inc. (NASDAQ: SGMT) increased by 38.57%, or $2.26, to $8.12 after announcing strategic updates for its clinical trials. Meanwhile, mining company Carmell Therapeutics Corporation (NASDAQ: CRML) climbed 25.54%, or $2.94, to $14.45. This followed its announcement of a letter of intent to acquire all outstanding shares of European Lithium Ltd.

In summary, today's top market gains are directly tied to company-specific news. Investors responded positively to strategic expansions, potential acquisitions, and successful clinical trial results, showing a strong focus on fundamental business growth.